Hydrochloric Acid

Hydrochloric Acid

SCHEMBL9867770

CCCN(CCC)C(=O)CN.Cl

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA2 known ✓ P00918 3/20 0.46
SIGMAR1 known ✓ Q99720 1/20 0.37
GLA known ✓ P06280 1/20 0.34
ALDH1A1 P00352 1/20 0.50
HPGD P15428 1/20 0.50
CA12 O43570 4/20 0.46
CA9 Q16790 4/20 0.46
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
POLB P06746 1/20 0.41
APEX1 P27695 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
TP53 P04637 1/20 0.39
CA1 P00915 3/20 0.39
LMNA P02545 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
TSPO P30536 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1380469 0.97 ALDH1A1 (0.52) ALDH1A1HPGDCA12CA9CA2
SCHEMBL4577559 0.83 CA12 (0.52) ALDH1A1HPGDCA12CA9CA2
SCHEMBL7748147 0.81 CA12 (0.39) ALDH1A1HPGDCA12CA9CA2
SCHEMBL1557690 0.79 CA12 (0.47) ALDH1A1HPGDCA12CA9CA2
SCHEMBL540900 0.79 CA12 (0.47) ALDH1A1HPGDCA12CA9CA2
SCHEMBL6386826 0.79 CA12 (0.47) ALDH1A1HPGDCA12CA9CA2
SCHEMBL31496780 0.79 CA12 (0.47) ALDH1A1HPGDCA12CA9CA2
SCHEMBL4210960 0.79 CA12 (0.47) ALDH1A1HPGDCA12CA9CA2
Hydrochloric Acid SCHEMBL10677864 0.79 LMNA (0.52) CA12CA9CA2CA1LMNA
Stearic Acid SCHEMBL16107259 0.79 GPR84 (0.59) ALDH1A1TSHRPOLBAPEX1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122070479-A Ultrasonic indicating device and method for monitoring ultrasonic treatment JP实验室股份有限公司 2026-05-19 CN claimed
WO-2025090061-A1 ULTRASONIC INDICATOR DEVICE AND METHOD FOR MONITORING ULTRASONICATION JP LABORATORIES, INC. (US) 2025-05-01 WO claimed
CN-122070479-A Ultrasonic indicating device and method for monitoring ultrasonic treatment JP实验室股份有限公司 2026-05-19 CN disclosed
US-20260117042-A1 THERMOPLASTIC RESIN COMPOSITION, MOLDED ARTICLE, AND COMPONENT FOR TELECOMMUNICATION APPARATUS ASAHI KASEI KABUSHIKI KAISHA (JP) 2026-04-30 US disclosed
EP-4679943-A1 THERMOPLASTIC RESIN COMPOSITION, MOLDED ARTICLE AND COMMUNICATION DEVICE COMPONENT Asahi Kasei Kabushiki Kaisha (JP) 2026-01-14 EP disclosed
EP-4613915-A1 METHOD OF PRODUCING COLORED OXIDE FILMS ON VALVE METAL PRODUCTS Politechnika Slaska (PL) 2025-09-10 EP disclosed
CN-119978790-A Mineral filled polyamide molding compounds EMS化学股份公司 2025-05-13 CN disclosed
WO-2025090061-A1 ULTRASONIC INDICATOR DEVICE AND METHOD FOR MONITORING ULTRASONICATION JP LABORATORIES, INC. (US) 2025-05-01 WO disclosed
EP-4249557-B1 COMPONENT FOR COMMUNICATION DEVICES ASAHI CHEMICAL IND (JP) 2024-12-04 EP disclosed
EP-3971239-B1 RESIN COMPOSITION AND MOLDED ARTICLE ASAHI CHEMICAL IND (JP) 2024-11-13 EP disclosed
WO-2024190428-A1 THERMOPLASTIC RESIN COMPOSITION, MOLDED ARTICLE AND COMMUNICATION DEVICE COMPONENT 旭化成株式会社 2024-09-19 WO disclosed
US-20220411580-A1 POLYAMIDE COMPOSITION WHICH IS DYED IN BLACK, PRODUCTION AND USE THEREOF BASF SE (DE) 2022-12-29 US disclosed
US-20220372283-A1 RESIN COMPOSITION AND SHAPED PRODUCT ASAHI KASEI KABUSHIKI KAISHA (JP) 2022-11-24 US disclosed
US-20220251375-A1 RESIN COMPOSITION AND MOLDED PRODUCT ASAHI KASEI KABUSHIKI KAISHA (JP) 2022-08-11 US disclosed
US-20220177701-A1 POLYAMIDE MOLDING COMPOUNDS HAVING INCREASED HYDROLYSIS RESISTANCE BASF SE (DE) 2022-06-09 US disclosed
US-20220145046-A1 THERMOPLASTIC MOLDING COMPOSITION BASF SE (DE) 2022-05-12 US disclosed
EP-3971239-A1 RESIN COMPOSITION AND MOLDED ARTICLE Asahi Kasei Kabushiki Kaisha (JP) 2022-03-23 EP disclosed
US-5026711-A Prevention and treatment of cardiovascular disorders and infections states; anxiolytic and anti-allergic agents SANOFI (FR) 1991-06-25 US disclosed
US-4996213-A For treating nervous system disorders SANOFI (FR) 1991-02-26 US disclosed
US-4788188-A ANTICONVULSANTS, SEDATIVES, ANXIOLYTIC AGENTS SANOFI (S.A.) (FR) 1988-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260117042-A1 THERMOPLASTIC RESIN COMPOSITION, MOLDED ARTICLE, AND COMPONENT FOR TELECOMMUNICATION APPARATUS GJB2, GJA1, TAS1R2 CA2 4506/4885SIGMAR1 4823/4885GLA 4682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.